Canada markets open in 2 hours 18 minutes

Fleury S.A. (FLRY3.SA)

São Paulo - São Paulo Delayed Price. Currency in BRL
Add to watchlist
14.92-0.05 (-0.33%)
At close: 05:07PM BRT

Fleury S.A.

Avenida General Valdomiro de Lima, 508
Jabaquara
São Paulo, SP 04344-903
Brazil
55 11 5014 7200
https://ri.fleury.com.br

Sector(s)Healthcare
IndustryDiagnostics & Research
Full Time Employees16,700

Key Executives

NameTitlePayExercisedYear Born
Ms. Jeane Mike TsutsuiCEO & Member of Exec. BoardN/AN/AN/A
Mr. Jose Antonio de Almeida FilippoExec. Director of Fin., Investor Relations and Legal & Member of Exec. BoardN/AN/A1960
Mr. Claudio Almeida PradoExec. Director of New Links & Member of Exec. BoardN/AN/AN/A
Mr. Edgar Gil RizzattiMedical, Technical & Process Exec. Director and Member of Exec. BoardN/AN/AN/A
Rodrigo MansoInvestor Relations Sr. Mang.N/AN/AN/A
Mr. Fernando Aguiar CamargoSec.N/AN/AN/A
Mr. Luís Mário BilenkyExec. Officer of Commercial and MarketingN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in BRL.

Description

Fleury S.A., together with its subsidiaries, provides medical services in the diagnostic, treatment, clinical analysis, health management, medical care, orthopedics, and ophthalmology areas in Brazil. The company operates through three segments: Diagnostic Medicine, Integrated Medicine, and Dental. It provides laboratory and image exam, diagnostic information, check-up and reference laboratory, genomics, clinic day, center of infusions, dental imaging exam, dental radiology, and diagnostic imaging services. The company also offers Saúde I, a digital healthcare platform that provides services, including teleconsultations, medical, diagnostic medicine exams, and procedures; and corporate solutions and face-to-face primary care, as well as solutions for physicians with digital office and medical education. It operates 284 customer service units and 31 hospital-based units under the Labs a+, Felippe Mattoso, Lafe, Fleury, a+SP, CIP, Moacir Cunha, Vita, inlab, Weinmann, Serdil, a+ and Diagmax, a+, IRN / CPC, Diagnosis a+, a+BA, and Pretti and Bioclinic brand names. The company was founded in 1926 and is headquartered in São Paulo, Brazil.

Corporate Governance

Fleury S.A.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.